Diagnosis of Parkinson Disease

Making an accurate diagnosis of Parkinson’s particularly in its early stages — is difficult. The use of functional neuroimaging in neurodegenerative diseases has increased in recent years, with applications in research in the underlying pathophysiology, aiding in diagnosis, or evaluating new treatments. In Parkinson's disease (PD), these imaging ways have expanded our understanding of the disease on the far side dopaminergic deficits area unit of diagnostics and Neuroimaging for Parkinson disease are Clinical pathological and genetic overlap in parkinsonism, Detecting prodromal Parkinson’s disease, Nuclear imaging to study Laboratory investigations supporting the diagnosis of MSA, PSP and CBD, Utility of next generation sequencing in the diagnosis of parkinsonian disorders, Clinic-genetic correlations in parkinsonian disorders, Therapeutic strategies in genetic forms of proteinopathies,  pathophysiology to new treatment strategies Insights from the laboratory and Disease-modifying, animal models and Symptomatic treatments, Update on surgical and medical treatment of the dystonia’s, Instrumental analysis of tremor, Instrumental analysis of parkinsonian symptoms, analysis of gait and postural reflexes, Neuroprotective treatments and Complementary Therapy.

Accurate diagnosis of Parkinson Disease, and other forms of parkinsonism, and ET can be a challenge. The most common differential diagnoses include essential tremor (ET); atypical parkinsonism such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), diffuse Lewy body (DLB) disease, and corticobasal degeneration (CBD); Alzheimer disease; and vascular, drug-induced, and psychogenic parkinsonism. In a study of 100 patients clinically diagnosed with Parkinson Disease by a general neurologist, autopsy findings revealed a diagnostic accuracy of 76%. In another study of patients diagnosed with parkinsonism in the community, 15% were misdiagnosed with PD and 19% had PD but were diagnosed with another disorder. The majority of those misdiagnoses were ET. The autopsy is the only way to definitively diagnose PD The correct diagnosis depends largely on the expertise of the physician and a good clinical history. In difficult cases, neuroimaging may serve as a tool to improve diagnostic accuracy, particularly between PD and ET.

  • Instrumental analysis of tremor
  • Instrumental analysis of parkinsonian symptoms
  • Complementary Therapy
  • Neuroprotective treatments
  • Analysis of gait and postural reflexes
  • Detecting prodromal Parkinsons disease
  • Clinical pathological and genetic overlap in parkinsonism
  • Nuclear imaging to study parkinsonian disorders
  • Disease modifying and symptomatic treatments
  • Myoclonus, Etiology, pathophysiology and treatment
  • Clinico-genetic correlations in parkinsonian disorders
  • Therapetuic strategies in genetic forms of proteinopathies
  • Update on medical and surgical treatment of the dystonias
  • Laboratory investigations supporting the diagnosis of MSA and PSP/CBD
  • Utility of next generation sequencing in the diagnosis of parkinsonian disorders
  • Pathophysiology to new treatment strategies: Insights from the laboratory and animal models
  • Huntington’s disease: From natural history studies to experimental therapeutics

Related Conference of Diagnosis of Parkinson Disease

November 20-21, 2017

28th International Conference on Psychiatry & Mental Health

Melbourne, Australia
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
June 18-20, 2018

25th World Congress on Neurology & Neuroscience

Dublin, Ireland

July 27-28, 2018

World Summit on Spine and Spinal Disorders

Atlanta, USA
June 18-20, 2018

World Congress on Neurology & Psychiatry

Tokyo, Japan
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
September 05-06, 2018

4th Global Congress on Spine and Spinal Disorders

Auckland, New Zealand
August 06-08, 2018

26th European Neurology Congress

Madrid, Spain
August 20-22, 2018

International Conference on Dementia & Dementia Care

Singapore City, Singapore
August 29-30, 2018

4th World Congress on Parkinsons & Huntington Disease

Zurich, Switzerland
August 29-30, 2018

4th International Conference on Epilepsy & Treatment

Zurich, Switzerland
August 31-September 01 2018

World Summit on Stroke & Neurological Disorders

Boston, Massachusetts, USA
September 07-08, 2017

Global Experts Meeting on Brain Disorders

Macau, Hong Kong
September 10-12, 2018

International Conference on

Dublin, Ireland
September 19-20, 2018

4th World Congress on Epilepsy and Treatment

September, 20-22

International Conference on Neurology & Health Care

Lisbon, Portugal
September 21-22, 2018

3rd International Conference on Sleep Disorders and Medicine

Philadelphia, USA
September 24-25, 2018

Annual Congress on Neuroscience & Therapeutics

Toronto, Canada
October 1-2 2018

3rd World Congress on Pediatric Neurology

Osaka, Japan
November 16-17, 2017

Global Experts Meeting on Neurological Disorders and Stroke

Melbourne, Australia
Oct 12-13, 2017

Internatinal Meeting on Addiction Congress

Osaka, Japan
Oct 12-13, 2017

Global Meeting on Dual Diagnosis and Addiction

Auckland, Newzeland
September 21-22, 2018

International Conference on Brain Disorders and Dementia Care

Philadelphia, USA
November 12-13, 2018

4th International Conference on Spine and Spinal Disorders

Frankfurt, Germany
November 12-13, 2018

30th International Conference on Mental and Behavioral Health

Melbourne, Australia
Nov 13-14, 2017

Gobal Experts Meeting on Neuroscience and Neurochemistry

Melbourne, Australia

Diagnosis of Parkinson Disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in